As on 3rd Nov 2021 PANACEABIO Share Nqe kaw @ 210.15 thiab peb RECOMMEND Tshuaj Muag rau LONG-TERM nrog Stoploss ntawm 281.11 & Muag muag rau luv luv nrog Stoploss ntawm 276.05 peb kuj cia siab tias STOCK yuav ua raws li qhov tseem ceeb.
Puas Panacea Biotec yog lub tuam txhab zoo?
khoom zoo thiab siv tau.
Panacea biotec yog lub tuam txhab tswj hwm. zoo li USFDA, MHRA pom zoo lub tuam txhab. chaw ua hauj lwm muaj zog heev thiab zoo. kab lis kev cai ntawm tuam txhab yog zoo thaum ua hauj lwm.
Vim li cas Panacea Biotec poob?
Shares ntawm Panacea Biotec poob 8 feem pua rau Rs 214 ntawm National Stock Exchange (NSE) rau hnub Friday, poob 13 feem pua hauv ob hnub ua lag luam dhau los, tom qab Serum Institute of India tau muag nws cov ceg txheem ntseeg hauv lub tuam txhab los ntawm qhib kev lag luam.
YPanacea Biotec yog dab tsi?
Panacea Biotec muaj ntau yam khoom rau kho mob caj dab, haemorrhoids, acid reflux, thiab lwm yam teeb meem gastrointestinal. Nws cov khoom tseem ceeb tshaj plaws yog Sitcom, euphorbia prostata extract uas pab ntau qib ntawm hemorrhoids.
Puas Panacea Biotec thiab Serum Institute Tib?
Serum Institute of India CEO Adar Poonawalla rau hnub Monday tau tshem tawm nws tag nrho cov ceg txheem ntseeg hauv Panacea Biotec suav txog 5.15 feem pua ntawm cov tuam txhab rau ₹118 crore, los ntawm kev qhib kev lag luam kev lag luam.. Cov shares tau xaiv los ntawm Serum Institute of India (SII).
